Kesimpta® (Ofatumumab) Data Show Long-term Preservation of IgG/IgM Levels and no Increased Risk of Serious Infections in People Living with Multiple Sclerosis
June 22, 2021
Today, Novartis disclosed new data showing mean IgG and IgM levels remain unchanged in adults with relapsing multiple sclerosis (RMS) treated with Kesimpta® (ofatumumab) over 3.5 years. The ongoing open label extension of the ALITHIOS study ...
chat_bubble0 Comment
visibility34 Views
Remote Healthcare Market Size Worth $23.9B by 2028
June 22, 2021
The global remote healthcare market size is expected to reach USD 23.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.0% from 2021 to 2028. COVID-19 ...
chat_bubble0 Comment
visibility54 Views
Implantable Brain Device Relieves Pain in Early Study
June 22, 2021
A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study finds. The experiments, conducted by investigators at NYU Grossman School of Medicine, offer what the researchers call a “blueprint” for ...
chat_bubble0 Comment
visibility61 Views
